The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 72 | 0.0x | 20.1x | Above average | |
Growth | 92 | — | 5.6% | Above average | |
Quality | 6 | -371.2% | 7.6% | Below average | |
Safety | 71 | 0.7x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Sionna Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Sionna Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
SION stock has witnessed a notable positive revision in its average price target, rising from $48 to $54, representing a 12.5% increase over the last 30 days. Interestingly, this rise came by consensus from the same number of analysts (6 analysts), indicating a collective optimistic reassessment of the company's clinical assets without the entry of new parties, with the forecast range narrowing between $50 and $58, reflecting low dispersion and high confidence in the stock's fair value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.